Arthralgia: Clinical Trials

5 terminated. 5 Phase 3.

By phase and status

Phase	Trials	Status
Phase 3	5	Terminated 5

Follow Arthralgia: new trials by email Literature Review of Arthralgia trials Research Report on Arthralgia

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Rofecoxib Efficacy and Safety Evaluation Trial in Hemophilic Arthropathy TRM-201 (Rofecoxib), Placebo - Hemophilic Arthropathy	Phase 3	Terminated	Tremeau Pharmceuticals, Inc.	2	2021-06-02	2022-10-27
A 12 Week Study to Assess Changes in Joint Inflammation Using Ultrasonography in Patients With Rheumatoid Arthritis (RA) Certolizumab Pegol - Rheumatoid Arthritis	Phase 3	Terminated	UCB Pharma	3	2011-02-01	2018-08-01
Efficacy and Safety of Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Shoulder, Elbow or Knee Tendonitis or Bursitis Ketoprofen Topical Patch 20%, Placebo - Tendonitis, Bursitis	Phase 3	Terminated	Alkemira SA	381	2007-02-07	2026-09-30
A Study to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) in the Treatment of Acute Pain After Hip Replacement Surgery Compared With Oxycodone and Placebo Followed by a Voluntary Open-Label Extension For Safety Tapentadol IR (CG5503), Placebo, Oxycodone HCL IR - Arthroplasty	Phase 3	Terminated	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	367	2006-10-01	2014-04-21
Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid Arthritis Etanercept, Placebo - Juvenile Rheumatoid Arthritis	Phase 3	Terminated	Amgen	19	2001-06-04	2019-09-25

Narrower conditions

Pain (3)  ·  Arthritis (1)  ·  Arthritis, Juvenile (1)  ·  Arthritis, Rheumatoid (1)  ·  Bursitis (1)  ·  Cartilage Diseases (1)  ·  Exanthema (1)  ·  Fever (1)  ·  Hemophilia A (1)  ·  Inflammation (1)  ·  Shoulder Pain (1)  ·  Tendinopathy (1)  ·  Tendon Injuries (1)

Broader conditions

Joint Diseases (5)  ·  Musculoskeletal Diseases (5)  ·  Neurologic Manifestations (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Signs and Symptoms (5)  ·  Connective Tissue Diseases (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Autoimmune Diseases (2)  ·  Immune System Diseases (2)  ·  Pain (2)  ·  Rheumatic Diseases (2)  ·  Arthritis (1)  ·  Blood Coagulation Disorders (1)  ·  Blood Coagulation Disorders, Inherited (1)

Interventions

Certolizumab Pegol (1)  ·  Etanercept (1)  ·  Tapentadol (1)  ·  rofecoxib (1)

Sponsors

Alkemira SA (1)  ·  Amgen (1)  ·  Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (1)  ·  Tremeau Pharmceuticals, Inc. (1)  ·  UCB Pharma (1)

Countries

United States (4)  ·  Canada (2)  ·  Spain (2)  ·  Australia (1)  ·  Belgium (1)  ·  Finland (1)  ·  Italy (1)  ·  New Zealand (1)  ·  Poland (1)  ·  Sweden (1)  ·  Turkey (Türkiye) (1)  ·  Ukraine (1)  ·  United Kingdom (1)

Top investigators

Judith Boice, PhD (1)